Xtant Medical Holdings XTNT Sales & Marketing
Sales & Marketing at other companies
Other financials
Where this comes from
Reported directly by Xtant Medical Holdings in its filing.
Tagged under the XBRL concept us-gaap:SellingAndMarketingExpense.
The official record: Xtant Medical Holdings’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xtant Medical Holdings's sales & marketing.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Xtant Medical Holdings's sales & marketing?
- Xtant Medical Holdings (XTNT) reported sales & marketing of $8.19M in Q1 2026.
- How has Xtant Medical Holdings's sales & marketing changed year-over-year?
- Xtant Medical Holdings's sales & marketing decreased by 26.9% year-over-year, from $11.2M to $8.19M.
- What is the long-term trend for Xtant Medical Holdings's sales & marketing?
- Over 4 years (2021 to 2025), Xtant Medical Holdings's sales & marketing has grown at a 21.3% compound annual growth rate (CAGR), from $21.03M to $45.51M.
- What does sales & marketing mean?
- Costs of selling products and services including sales force compensation, commissions, marketing campaigns, trade shows, and customer acquisition expenses.